Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease
Open Access
- 1 July 2021
- journal article
- Published by Elsevier in AACE Clinical Case Reports
- Vol. 7 (4) , 273-276
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (KL2TR002530, UL1TR002529, 5T32-DK-065549-15)
- National Institutes of Health (KL2TR002530, UL1TR002529, 5T32-DK-065549-15)
- National Institute of Diabetes and Digestive and Kidney Diseases (KL2TR002530, UL1TR002529, 5T32-DK-065549-15)
This publication has 13 references indexed in Scilit:
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of ThyrotoxicosisThyroid®, 2016
- Use of Antihistamines After Serious Allergic Reaction to Methimazole in Pediatric Graves’ DiseasePediatrics, 2014
- Hyperthyroidism in Childhood: Causes, when and how to treatJournal of Clinical Research in Pediatric Endocrinology, 2012
- Pediatric Thyroid Disease: When is Surgery Necessary, and Who Should be Operating on Our Children?Journal of Clinical Research in Pediatric Endocrinology, 2012
- Incidence of thyrotoxicosis in childhood: a national population based study in the UK and IrelandClinical Endocrinology, 2010
- Adverse Events Associated with Methimazole Therapy of Graves' Disease in ChildrenInternational Journal of Pediatric Endocrinology, 2010
- Adverse Events Associated with Methimazole Therapy of Graves' Disease in ChildrenInternational Journal of Pediatric Endocrinology, 2010
- Ending Propylthiouracil-Induced Liver Failure in ChildrenNew England Journal of Medicine, 2009
- A 36-Year Retrospective Analysis of the Efficacy and Safety of Radioactive Iodine in Treating Young Graves’ PatientsThe Journal of Clinical Endocrinology & Metabolism, 2004
- The Management of Graves’ Disease in Children, with Special Emphasis on Radioiodine TreatmentThe Journal of Clinical Endocrinology & Metabolism, 1998